XML 67 R56.htm IDEA: XBRL DOCUMENT
v3.25.2

SUBSEQUENT EVENTS - (Details) - Subsequent Event - Inozyme Pharma Inc $ / shares in Units, $ in Millions | Jul. 01, 2025 USD ($) $ / shares
--- | ---
Subsequent Event [Line Items] |
Acquisition price per share (in usd per share) | $ / shares | $ 4.00
Expected transaction price | $ | $ 270.0

X
- Definition Asset Acquisition, Price Per Share + References No definition available. + Details
Name: | bmrn_AssetAcquisitionPricePerShare
Namespace Prefix: | bmrn_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionPriceOfAcquisitionExpected
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=bmrn_InozymePharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |